Claude Linassier
-
- Lymphoma Diagnosis and Treatment 16
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 8
- Multiple Myeloma Research and Treatments 7
- Oncology top 5%
- Cancer Treatment and Pharmacology 9
- Genetics top 5%
-
- Renal cell carcinoma treatment 11
- Sarcoma Diagnosis and Treatment 10
- Prostate Cancer Treatment and Research 9
-
- Testicular diseases and treatments 9
- Co-authors
- Judit MarkovitsAlain Jacquemin‐SablonPhilippe FosséAnnette K. LarsenJ PierreJean Bernard Le PecqJean‐Bernard Le PecqJosiane Pierre
- Partner nations
- FranceUnited StatesSlovakia
In The Last Decade
Claude Linassier
93 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 119
- Pathology and Forensic Medicine 721
- Hematology 348
- Oncology 738
- Genetics 262
- Pulmonary and Respiratory Medicine 715
Countries citing papers authored by Claude Linassier
This map shows the geographic impact of Claude Linassier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Linassier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Linassier more than expected).
Fields of papers citing papers by Claude Linassier
This network shows the impact of papers produced by Claude Linassier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Linassier. The network helps show where Claude Linassier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claude Linassier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 0 | |
| 6 | 2020 | 9 | |
| 7 | 2019 | 12 | |
| 8 | 2017 | 3 | |
| 9 | 2015 | 80 | |
| 10 | 2015 | 14 | |
| 11 | 2012 | 20 | |
| 12 | 2010 | 71 | |
| 13 | 2002 | 32 | |
| 14 | 2002 | 12 | |
| 15 | 1998 | 1 | |
| 16 | 1994 | 4 | |
| 17 | 1994 | 0 | |
| 18 | 1992 | 12 | |
| 19 | 1992 | 4 | |
| 20 | [Primary non-Hodgkin's high grade malignant lymphoma of the digestive system. A prospective study of the combination of surgery-chemotherapy-radiotherapy]. | 1990 | 1 |
About Claude Linassier
Claude Linassier is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine, having authored 97 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (16 papers), Renal cell carcinoma treatment (11 papers), Sarcoma Diagnosis and Treatment (10 papers), Testicular diseases and treatments (9 papers), Cancer Treatment and Pharmacology (9 papers), Prostate Cancer Treatment and Research (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Multiple Myeloma Research and Treatments (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (721 citations), Hematology (348 citations) and Oncology (738 citations). Claude Linassier has collaborated with scholars based in France, United States and Slovakia. Frequent co-authors include Judit Markovits, Alain Jacquemin‐Sablon, Philippe Fossé, Annette K. Larsen, J Pierre, Jean Bernard Le Pecq, Jean‐Bernard Le Pecq, Josiane Pierre, Michel Pierre and Pierre Dubois. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.